Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.42%
Monthly Change
-11.86%
6 month change
-38.49%
Year Change
+6.32%
Previous Close
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Markets
US Stock Market
Healthcare
VSTM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
126.38 M
101.54 M
131.7 M
196.26 M
176.85 M
Total liabilities
94.16 M
130.43 M
164.13 M
160.21 M
192.38 M
Total equity
11.06 M
28.89 M
32.43 M
36.06 M
15.53 M
Total liabilities & shareholders' equities
126.38 M
101.54 M
131.7 M
196.26 M
176.85 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
News
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley подтверждает рейтинг "Покупать" для акций Verastem
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem сообщает о выручке $17,5 млн в 4 квартале от лечения рака
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Акции Revolution Medicines взлетели на 20% на фоне возможной покупки AbbVie
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Акции Verastem стабильны после подтверждения рейтинга Mizuho